Search Results

Analytical Procedure for Determination of Cyclooxygenase-2 Inhibitors in Biological Fluids by High Performance Liquid Chromatography: A Review

Author: Carlucci, Giuseppe

Source: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Cu, Volume 8, Number 1, March 2009 , pp. 22-37(16)

Publisher: Bentham Science Publishers

Effects of Nimesulide, Acetylsalicylic Acid, Ibuprofen and Nabumetone on Cyclooxygenase-1- and Cyclooxygenase-2-Mediated Prostanoid Production in Healthy Volunteers ex vivo

Authors: Kerola, Markku; Vuolteenaho, Katriina; Kosonen, Outi; Kankaanranta, Hannu; Sarna, Seppo; Moilanen, Eeva

Source: Basic & Clinical Pharmacology & Toxicology, Volume 104, Number 1, January 2009 , pp. 17-21(5)

Publisher: Blackwell Publishing

Safety of the Nonselective NSAID Nabumetone: Focus on Gastrointestinal Tolerability

Author: Bannwarth, Bernard

Source: Drug Safety, Volume 31, Number 6, 2008 , pp. 485-503(19)

Publisher: Adis International

Improved Preparation of Nabumetone by Raney Ni Catalytic Hydrogenation

Authors: Yang, Fan; Wang, Lixin; Li, Xianguo; Shen, Jianfen; Wang, Jiyu; Yu, Xiaoqi

Source: Letters in Organic Chemistry, Volume 5, Number 3, April 2008 , pp. 191-193(3)

Publisher: Bentham Science Publishers

Nabumetone and hydroxyzine launched in US.

Source: Inpharma, Volume 1, Numbers 1630-1631, 2008-03-22 , pp. 18-18(1)

Publisher: Adis International

Risk of upper gastrointestinal events with the use of various NSAIDs: A case-control study in a general population

Authors: Helin-Salmivaara, Arja; Saarelainen, Sami; Grönroos, Juha M.; Vesalainen, Risto; Klaukka, Timo; Huupponen, Risto

Source: Scandinavian Journal of Gastroenterology, Volume 42, Number 8, 2007 , pp. 923-932(10)

Publisher: Informa Healthcare

Systematic review of trials of the effect of continued use of oral non-selective NSAIDs on blood pressure and hypertension

Authors: Morrison, Alan; Ramey, Dena Rosen; van Adelsberg, Janet; Watson, Douglas J.

Source: Current Medical Research and Opinion, Volume 23, Number 10, October 2007 , pp. 2395-2404(10)

Publisher: Informa Healthcare

Nabumetone: Systemic hypersensitivity in elderly patients: 2 case reports

Source: Reactions, Volume 1, Number 1170, 2007-09-22 , pp. 26-26(1)

Publisher: Adis International

Withdrawal of COX-2 selective inhibitors rofecoxib and valdecoxib: impact on NSAID and gastroprotective drug prescribing and utilization

Authors: Sun, Shawn X.; Lee, Kwan Y.; Bertram, Carl T.; Goldstein, Jay L.

Source: Current Medical Research and Opinion, Volume 23, Number 8, August 2007 , pp. 1859-1866(8)

Publisher: Informa Healthcare

Risk of serious upper gastrointestinal events with concurrent use of NSAIDs and SSRIs: a case-control study in the general population

Authors: Helin-Salmivaara, Arja; Huttunen, Teppo; Grönroos, Juha; Klaukka, Timo; Huupponen, Risto

Source: European Journal of Clinical Pharmacology, Volume 63, Number 4, April 2007 , pp. 403-408(6)

Publisher: Springer

Nabumetone: First report of Stevens-Johnson syndrome: case report

Source: Reactions, Volume 1, Number 1124, 2006-10-21 , pp. 15-15(1)

Publisher: Adis International

Temporal Relationship between Use of NSAIDs, Including Selective COX-2 Inhibitors, and Cardiovascular Risk

Authors: Motsko, Stephen P.; Rascati, Karen L.; Busti, Anthony J.; Wilson, James P.; Barner, Jamie C.; Lawson, Kenneth A.; Worchel, Jason

Source: Drug Safety, Volume 29, Number 7, 2006 , pp. 621-632(12)

Publisher: Adis International

Celecoxib/nabumetone: Urticaria (first report with nabumetone), oedema, skin eruptions and bronchospasm in an elderly patient: case report

Source: Reactions, Volume 1, Number 1103, 2006-05-27 , pp. 5-5(1)

Publisher: Adis International

Tolerance of diclofenac after hypersensitivity to celecoxib and to nabumetone

Authors: Wyplosz, Benjamin; Vautier, Sarah; Lillo-Le Louët, Agnès; Capron, Loïc

Source: British Journal of Clinical Pharmacology, Volume 61, Number 4, April 2006 , pp. 474-474(1)

Publisher: Blackwell Publishing

Low Direct Cytotoxicity of Nabumetone on Gastric Mucosal Cells

Authors: Arai, Yasuhiro; Tanaka, Ken-Ichiro; Ushijima, Hironori; Tomisato, Wataru; Tsutsumi, Shinji; Aburaya, Mayuko; Hoshino, Tatsuya; Yokomizo, Kazumi; Suzuki, Keitarou; Katsu, Takashi; Tsuchiya, Tomofusa; Mizushima, Tohru

Source: Digestive Diseases and Sciences, Volume 50, Number 9, September 2005 , pp. 1641-1646(6)

Publisher: Springer

The labelling for US Relafen [nabumetone] has been revised to include a stronger precaution on the renal effects of the drug

Source: Reactions, Volume 1, Number 1066, 2005-08-27 , pp. 2-2(1)

Publisher: Adis International

The labelling for US Relafen [nabumetone] has been revised to include a stronger precaution on the renal effects of the drug

Source: Inpharma, Volume 1, Number 1502, 2005-08-27 , pp. 20-20(1)

Publisher: Adis International

Interactions of Nabumetone with -Cyclodextrin Studied by Fluorescence Measurements

Author: Al-Rawashdeh, Nathir

Source: Journal of Inclusion Phenomena and Macrocyclic Chemistry, Volume 51, Numbers 1-2, February 2005 , pp. 27-32(6)

Publisher: Springer

Cyclo-oxygenase 2 inhibitor, nabumetone, inhibits proliferation in chronic myeloid leukemia cell lines

Authors: Vural, Filiz; Özcan, Mehmet Ali; Özsan, Güner Hayri; Ate, Halil; Demirkan, Fatih; Pikin, Özden; Ündar, Bülent

Source: Leukemia and Lymphoma, Volume 46, Number 5, May 2005 , pp. 753-756(4)

Publisher: Informa Healthcare

Interactions of Nabumetone with -Cyclodextrin Studied by Fluorescence Measurements

Author: Al-Rawashdeh, Nathir

Source: Journal of Inclusion Phenomena and Macrocyclic Chemistry, Volume 51, Number 1, February 2005 , pp. 27-32(6)

Publisher: Springer